Fingerprint
Dive into the research topics of 'Long-term outcomes in KEYNOTE-052: Phase II study investigating first-line pembrolizumab in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically